BNTX
Price:
$114.13
Market Cap:
$26.34B
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, a preclinical stage product for non-small cell lung cancer. It also develops neoantigen specific immunotherapies, such as Autogene cevumeran (BNT122),...[Read more]
Industry
Biotechnology
IPO Date
2019-10-10
Stock Exchange
NASDAQ
Ticker
BNTX
According to BioNTech SE’s latest financial reports and current stock price. The company's current PE Ratio is -56.78. This represents a change of -1102.45% compared to the average of 5.66 of the last 4 quarters.
The mean historical PE Ratio of BioNTech SE over the last ten years is 117.67. The current -56.78 PE Ratio has changed -4925.51% with respect to the historical average. Over the past ten years (40 quarters), BNTX's PE Ratio was at its highest in in the September 2023 quarter at 38.33. The PE Ratio was at its lowest in in the December 2018 quarter at -520.89.
Average
117.67
Median
1.81
Minimum
-58.66
Maximum
1.03K
Discovering the peaks and valleys of BioNTech SE PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 589.08%
Maximum Annual PE Ratio = 1.03K
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -58.66
Year | PE Ratio | Change |
---|---|---|
2023 | 24.93 | 589.08% |
2022 | 3.62 | -32.68% |
2021 | 5.37 | -99.48% |
2020 | 1.03K | -2997.10% |
2019 | -35.66 | -39.21% |
2018 | -58.66 | 86.72% |
2017 | -31.42 | -Infinity% |
The current PE Ratio of BioNTech SE (BNTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.31
5-year avg
206.28
10-year avg
117.67
BioNTech SE’s PE Ratio is less than Novavax, Inc. (-4.78), less than CohBar, Inc. (-0.15), less than Ginkgo Bioworks Holdings, Inc. (-0.75), less than CRISPR Therapeutics AG (-14.56), less than Ocean Biomedical, Inc. (0), less than Enveric Biosciences, Inc. (-0.46), less than Hepion Pharmaceuticals, Inc. (-0.27), less than Elevation Oncology, Inc. (-0.15), less than AVROBIO, Inc. (-0.79), less than PTC Therapeutics, Inc. (2.07), less than Krystal Biotech, Inc. (-7.70), less than Sarepta Therapeutics, Inc. (86.92), less than Iovance Biotherapeutics, Inc. (95.43), less than Madrigal Pharmaceuticals, Inc. (-5.54), less than null (-13.08),
Company | PE Ratio | Market cap |
---|---|---|
-4.78 | $1.36B | |
-0.15 | $1.77M | |
-0.75 | $535.70M | |
-14.56 | $3.49B | |
0 | $20.54M | |
-0.46 | $3.15M | |
-0.27 | $3.48M | |
-0.15 | $33.34M | |
-0.79 | $5.24M | |
2.07 | $3.50B | |
-7.70 | $4.56B | |
86.92 | $11.64B | |
95.43 | $2.28B | |
-5.54 | $6.80B | |
-13.08 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioNTech SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioNTech SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BioNTech SE's PE Ratio?
How is the PE Ratio calculated for BioNTech SE (BNTX)?
What is the highest PE Ratio for BioNTech SE (BNTX)?
What is the 3-year average PE Ratio for BioNTech SE (BNTX)?
What is the 5-year average PE Ratio for BioNTech SE (BNTX)?
How does the current PE Ratio for BioNTech SE (BNTX) compare to its historical average?